pentetic acid and sorbitol

pentetic acid has been researched along with sorbitol in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19908 (53.33)18.7374
1990's6 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hunt, JV; Wolff, SP1
Engel, A; Gylys-Morin, V; Haghighi, P; Hajek, PC; Kramer, F; Neumann, CH; Resnick, D; Sartoris, DJ1
Kawamura, J; Keyaki, A; Kuroda, Y; Makita, Y; Matsuo, M; Miki, Y; Nishizawa, S1
Agnoli, AL; Herrmann, S1
Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK1
Kieffer, SA1
Bielke, G; Grigat, M; Higer, HP; Jungke, M; Just, M; Kunze, S; Meindl, S; Pedrosa, P; Voth, D1
Bravo, S; Krol, G; Sze, G1
Niendorf, HP; Seifert, W1
Niendorf, HP1
Braffman, BH; Brorson, JR; Goldberg, HI; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH1
Atlas, SW; Galetta, S; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH1
Felix, R; Laniado, M; Schörner, W; Speck, U; Weinmann, HJ1
Laniado, M; Mützel, W; Weinmann, HJ1

Reviews

1 review(s) available for pentetic acid and sorbitol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

3 trial(s) available for pentetic acid and sorbitol

ArticleYear
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
    Radiology, 1990, Volume: 174, Issue:1

    Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States

1990
Gadopentetate dimeglumine: observations on the clinical research process.
    Radiology, 1990, Volume: 174, Issue:1

    Topics: Clinical Trials as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Research Design; Sorbitol; United States; United States Food and Drug Administration

1990
Serum iron and serum bilirubin after administration of Gd-DTPA-dimeglumine. A pharmacologic study in healthy volunteers.
    Investigative radiology, 1988, Volume: 23 Suppl 1

    Topics: Adult; Bilirubin; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Iron; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Random Allocation; Sorbitol

1988

Other Studies

11 other study(ies) available for pentetic acid and sorbitol

ArticleYear
Oxidative glycation and free radical production: a causal mechanism of diabetic complications.
    Free radical research communications, 1991, Volume: 12-13 Pt 1

    Topics: Aging; Aldehydes; Animals; Benzoates; Benzoic Acid; Cattle; Chelating Agents; Chromatography, Affinity; Diabetes Complications; Diabetes Mellitus; Free Radical Scavengers; Free Radicals; Glucose; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Oxidation-Reduction; Pentetic Acid; Proteins; Sorbitol

1991
The effect of intra-articular gadolinium-DTPA on synovial membrane and cartilage.
    Investigative radiology, 1990, Volume: 25, Issue:2

    Topics: Animals; Cartilage, Articular; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Injections, Intra-Articular; Knee Joint; Meglumine; Organometallic Compounds; Pentetic Acid; Rabbits; Sorbitol; Synovial Membrane

1990
Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Radiology, 1990, Volume: 177, Issue:1

    Topics: Adenoma; Adult; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Sorbitol

1990
[Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
    Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie, 1990, Volume: 43, Issue:8

    Topics: Astrocytoma; Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Neoplasm Staging; Oligodendroglioma; Organometallic Compounds; Pentetic Acid; Sorbitol

1990
[Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1988, Volume: 148, Issue:3

    Topics: Brain Diseases; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol

1988
Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
    Radiology, 1989, Volume: 170, Issue:3 Pt 1

    Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol; Spinal Cord Diseases; Spinal Cord Neoplasms; Spinal Diseases; Spinal Neoplasms; Time Factors

1989
Gadolinium-DTPA: a new contrast agent.
    Bristol medico-chirurgical journal (1963), 1988, Volume: 103, Issue:2

    Topics: Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol

1988
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
    Radiology, 1988, Volume: 169, Issue:1

    Topics: Adult; Aged; Blood-Brain Barrier; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Time Factors

1988
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Annals of neurology, 1987, Volume: 21, Issue:3

    Topics: Adult; Aged; Brain; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Tomography, X-Ray Computed

1987
First use of GdDTPA/dimeglumine in man.
    Physiological chemistry and physics and medical NMR, 1984, Volume: 16, Issue:2

    Topics: Adult; Contrast Media; Drug Evaluation; Gadolinium; Humans; Kidney; Magnetic Resonance Spectroscopy; Male; Meglumine; Pentetic Acid; Sorbitol; Urinary Bladder

1984
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
    Physiological chemistry and physics and medical NMR, 1984, Volume: 16, Issue:2

    Topics: Contrast Media; Drug Evaluation; Gadolinium; Humans; Injections, Intravenous; Kidney; Kinetics; Magnetic Resonance Spectroscopy; Meglumine; Metabolic Clearance Rate; Pentetic Acid; Sorbitol

1984